• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Liverome:一个经过精心策划的肝癌相关基因特征数据库,包含独立的上下文信息。

Liverome: a curated database of liver cancer-related gene signatures with self-contained context information.

机构信息

Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.

出版信息

BMC Genomics. 2011 Nov 30;12 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2164-12-S3-S3.

DOI:10.1186/1471-2164-12-S3-S3
PMID:22369201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3333186/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. A number of molecular profiling studies have investigated the changes in gene and protein expression that are associated with various clinicopathological characteristics of HCC and generated a wealth of scattered information, usually in the form of gene signature tables. A database of the published HCC gene signatures would be useful to liver cancer researchers seeking to retrieve existing differential expression information on a candidate gene and to make comparisons between signatures for prioritization of common genes. A challenge in constructing such database is that a direct import of the signatures as appeared in articles would lead to a loss or ambiguity of their context information that is essential for a correct biological interpretation of a gene's expression change. This challenge arises because designation of compared sample groups is most often abbreviated, ad hoc, or even missing from published signature tables. Without manual curation, the context information becomes lost, leading to uninformative database contents. Although several databases of gene signatures are available, none of them contains informative form of signatures nor shows comprehensive coverage on liver cancer. Thus we constructed Liverome, a curated database of liver cancer-related gene signatures with self-contained context information.

DESCRIPTION

Liverome's data coverage is more than three times larger than any other signature database, consisting of 143 signatures taken from 98 HCC studies, mostly microarray and proteome, and involving 6,927 genes. The signatures were post-processed into an informative and uniform representation and annotated with an itemized summary so that all context information is unambiguously self-contained within the database. The signatures were further informatively named and meaningfully organized according to ten functional categories for guided browsing. Its web interface enables a straightforward retrieval of known differential expression information on a query gene and a comparison of signatures to prioritize common genes. The utility of Liverome-collected data is shown by case studies in which useful biological insights on HCC are produced.

CONCLUSION

Liverome database provides a comprehensive collection of well-curated HCC gene signatures and straightforward interfaces for gene search and signature comparison as well. Liverome is available at http://liverome.kobic.re.kr.

摘要

背景

肝细胞癌(HCC)是全球第五大常见癌症。许多分子谱研究已经调查了与 HCC 的各种临床病理特征相关的基因和蛋白质表达变化,并产生了大量分散的信息,通常以基因特征表的形式呈现。发布的 HCC 基因特征数据库将对肝癌研究人员有用,他们可以检索候选基因的现有差异表达信息,并在特征之间进行比较,以确定常见基因的优先级。构建此类数据库的一个挑战是,直接导入文章中出现的特征会导致其上下文信息丢失或模糊,而这些信息对于正确解释基因表达变化的生物学意义至关重要。这个挑战源于出版的特征表中对比样本组的名称通常是缩写的、临时的,甚至是缺失的。如果没有人工整理,上下文信息就会丢失,导致数据库内容变得毫无意义。虽然有几个基因特征数据库,但它们都不包含有意义的特征形式,也没有全面涵盖肝癌。因此,我们构建了 Liverome,这是一个具有自我包含上下文信息的肝癌相关基因特征的精心整理数据库。

描述

Liverome 的数据覆盖范围比任何其他签名数据库都要大三倍多,包含 143 个来自 98 项 HCC 研究的签名,主要是微阵列和蛋白质组学,涉及 6927 个基因。这些特征经过后处理,以一种信息丰富且统一的表示形式呈现,并附有详细的摘要,从而使所有上下文信息都在数据库中明确地自我包含。这些特征根据十个功能类别进行了有意义的命名和组织,以便于浏览。其 Web 界面可方便地检索查询基因的已知差异表达信息,并比较特征以确定常见基因的优先级。通过对 HCC 进行案例研究,展示了 Liverome 收集数据的实用性,从中获得了有用的生物学见解。

结论

Liverome 数据库提供了全面的 HCC 基因特征集合,以及简单易用的基因搜索和特征比较界面。Liverome 可在 http://liverome.kobic.re.kr 上获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/d465e0e00dc0/1471-2164-12-S3-S3-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/03f1d8cf32ee/1471-2164-12-S3-S3-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/6cb1d64a4f73/1471-2164-12-S3-S3-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/4f66d3b3e52e/1471-2164-12-S3-S3-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/f049cb879546/1471-2164-12-S3-S3-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/d465e0e00dc0/1471-2164-12-S3-S3-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/03f1d8cf32ee/1471-2164-12-S3-S3-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/6cb1d64a4f73/1471-2164-12-S3-S3-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/4f66d3b3e52e/1471-2164-12-S3-S3-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/f049cb879546/1471-2164-12-S3-S3-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8383/3333186/d465e0e00dc0/1471-2164-12-S3-S3-5.jpg

相似文献

1
Liverome: a curated database of liver cancer-related gene signatures with self-contained context information.Liverome:一个经过精心策划的肝癌相关基因特征数据库,包含独立的上下文信息。
BMC Genomics. 2011 Nov 30;12 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2164-12-S3-S3.
2
CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.CellMinerHCC:一个基于微阵列的肝细胞癌细胞系表达数据库。
Liver Int. 2014 Apr;34(4):621-31. doi: 10.1111/liv.12292. Epub 2013 Sep 9.
3
Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients.鉴定肝癌患者中与 RNA 结合蛋白相关的基因特征。
Mol Med. 2020 Dec 9;26(1):125. doi: 10.1186/s10020-020-00252-5.
4
PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies.PAGER-CoV:冠状病毒病研究的综合途径、注释基因列表和基因特征集。
Nucleic Acids Res. 2021 Jan 8;49(D1):D589-D599. doi: 10.1093/nar/gkaa1094.
5
OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.OncoDB.HCC:一个揭示异常癌症靶基因和位点的肝细胞癌综合肿瘤基因组数据库。
Nucleic Acids Res. 2007 Jan;35(Database issue):D727-31. doi: 10.1093/nar/gkl845. Epub 2006 Nov 10.
6
LiverAtlas: a unique integrated knowledge database for systems-level research of liver and hepatic disease.肝脏图谱:一个独特的综合知识数据库,用于肝脏和肝脏疾病的系统水平研究。
Liver Int. 2013 Sep;33(8):1239-48. doi: 10.1111/liv.12173. Epub 2013 Apr 21.
7
dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.dbPHCC:一个用于肝细胞癌预后生物标志物的数据库,提供在线预后建模。
Biochim Biophys Acta. 2016 Nov;1860(11 Pt B):2688-95. doi: 10.1016/j.bbagen.2016.02.017. Epub 2016 Mar 2.
8
HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.HCCDB:肝细胞癌表达图谱数据库。
Genomics Proteomics Bioinformatics. 2018 Aug;16(4):269-275. doi: 10.1016/j.gpb.2018.07.003. Epub 2018 Sep 25.
9
dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.dBMHCC:一个全面的肝细胞癌 (HCC) 生物标志物数据库为新型 HCC 磷酸化生物标志物提供了可靠的预测系统。
PLoS One. 2020 Jun 4;15(6):e0234084. doi: 10.1371/journal.pone.0234084. eCollection 2020.
10
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.鉴定五个长链非编码 RNA 标志物以改善肝细胞癌患者的预后预测。
World J Gastroenterol. 2018 Aug 14;24(30):3426-3439. doi: 10.3748/wjg.v24.i30.3426.

引用本文的文献

1
Polypharmacology-Driven Discovery of ZAK-I-57: A Potent Multi-Targeted Benzoxazinone Small Molecule for Hepatocellular Carcinoma Therapy.基于多药理学的ZAK-I-57发现:一种用于肝细胞癌治疗的强效多靶点苯并恶嗪酮小分子
MedComm (2020). 2025 Jul 27;6(8):e70291. doi: 10.1002/mco2.70291. eCollection 2025 Aug.
2
Molecular dynamics simulation based prediction of T-cell epitopes for the production of effector molecules for liver cancer immunotherapy.基于分子动力学模拟预测肝癌免疫治疗效应分子的T细胞表位。
PLoS One. 2025 Jan 3;20(1):e0309049. doi: 10.1371/journal.pone.0309049. eCollection 2025.
3
Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver Cancer.

本文引用的文献

1
Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting.在肝癌发生过程中,相邻正常组织中的预测基因优先被 sCNV 改变,这可能是限制因素。
PLoS One. 2011;6(7):e20090. doi: 10.1371/journal.pone.0020090. Epub 2011 Jul 5.
2
CCancer: a bird's eye view on gene lists reported in cancer-related studies.癌症:从鸟瞰的角度看癌症相关研究中报告的基因列表。
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W118-23. doi: 10.1093/nar/gkq515. Epub 2010 Jun 6.
3
GeneSigDB--a curated database of gene expression signatures.
华蟾素注射液抗肝癌的核心成分及分子机制的验证。
Drug Des Devel Ther. 2024 Apr 23;18:1321-1338. doi: 10.2147/DDDT.S443305. eCollection 2024.
4
Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules.木鸡方颗粒抗肝癌作用中与免疫逃逸和细胞凋亡相关的可能机制。
World J Gastrointest Oncol. 2023 Mar 15;15(3):504-522. doi: 10.4251/wjgo.v15.i3.504.
5
Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology.基于网络药理学、分子对接和实验验证技术的肝积方治疗肝细胞癌的分子机制
Front Pharmacol. 2023 Jan 19;14:1016967. doi: 10.3389/fphar.2023.1016967. eCollection 2023.
6
Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of in Treating Hepatocellular Carcinoma.基于网络药理学的治疗肝细胞癌的活性植物化学成分及分子机制研究。
Int J Mol Sci. 2022 May 12;23(10):5400. doi: 10.3390/ijms23105400.
7
Network Pharmacology-Based Study on the Mechanism of for Hepatocellular Carcinoma Treatment.基于网络药理学的肝细胞癌治疗机制研究
Evid Based Complement Alternat Med. 2020 Oct 26;2020:8897918. doi: 10.1155/2020/8897918. eCollection 2020.
8
Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma.揭示隐丹参酮作为抗肝细胞癌治疗药物的作用机制
Front Pharmacol. 2020 Aug 13;11:1264. doi: 10.3389/fphar.2020.01264. eCollection 2020.
9
dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.dBMHCC:一个全面的肝细胞癌 (HCC) 生物标志物数据库为新型 HCC 磷酸化生物标志物提供了可靠的预测系统。
PLoS One. 2020 Jun 4;15(6):e0234084. doi: 10.1371/journal.pone.0234084. eCollection 2020.
10
Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation.通过网络药理学与实验评价相结合阐释华蟾素胶囊对肝细胞癌的药理机制
Front Pharmacol. 2020 Apr 3;11:414. doi: 10.3389/fphar.2020.00414. eCollection 2020.
GeneSigDB——一个经过精心整理的基因表达特征数据库。
Nucleic Acids Res. 2010 Jan;38(Database issue):D716-25. doi: 10.1093/nar/gkp1015. Epub 2009 Nov 24.
4
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer.COSMIC(癌症体细胞突变目录):一个用于研究人类癌症中获得性突变的资源。
Nucleic Acids Res. 2010 Jan;38(Database issue):D652-7. doi: 10.1093/nar/gkp995. Epub 2009 Nov 11.
5
dbDEPC: a database of differentially expressed proteins in human cancers.dbDEPC:人类癌症中差异表达蛋白数据库。
Nucleic Acids Res. 2010 Jan;38(Database issue):D658-64. doi: 10.1093/nar/gkp933. Epub 2009 Nov 9.
6
GLUT1 as a therapeutic target in hepatocellular carcinoma.GLUT1 作为肝细胞癌的治疗靶点。
Expert Opin Ther Targets. 2009 Dec;13(12):1411-27. doi: 10.1517/14728220903307509.
7
BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers.
Proteomics. 2009 Jul;9(14):3729-40. doi: 10.1002/pmic.200800593.
8
Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma.人类肝细胞癌中糖酵解相关蛋白的独特时空表达模式
Histochem Cell Biol. 2009 Jul;132(1):21-31. doi: 10.1007/s00418-009-0590-4. Epub 2009 Apr 7.
9
WGCNA: an R package for weighted correlation network analysis.WGCNA:一个用于加权相关网络分析的R软件包。
BMC Bioinformatics. 2008 Dec 29;9:559. doi: 10.1186/1471-2105-9-559.
10
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.ATP柠檬酸裂解酶:在非小细胞肺癌中的激活及其治疗意义
Cancer Res. 2008 Oct 15;68(20):8547-54. doi: 10.1158/0008-5472.CAN-08-1235.